These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain. Moraes TB; Zanin F; da Rosa A; de Oliveira A; Coelho J; Petrillo F; Wajner M; Dutra-Filho CS J Neurol Sci; 2010 May; 292(1-2):89-95. PubMed ID: 20226470 [TBL] [Abstract][Full Text] [Related]
23. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients. Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498 [TBL] [Abstract][Full Text] [Related]
24. A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients. Hazneci E; Karabulut AB; Oztürk C; Batçioğlu K; Doğan G; Karaca S; Eşrefoğlu M Int J Dermatol; 2005 Aug; 44(8):636-40. PubMed ID: 16101862 [TBL] [Abstract][Full Text] [Related]
25. Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria. Keshavarzi F; Rastegar M; Vessal M; Rafiei Dehbidi G; Khorsand M; Ganjkarimi AH; Takhshid MA Metab Brain Dis; 2018 Jun; 33(3):675-680. PubMed ID: 29270710 [TBL] [Abstract][Full Text] [Related]
26. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study. Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792 [TBL] [Abstract][Full Text] [Related]
27. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Beevi SS; Rasheed MH; Geetha A Clin Chim Acta; 2007 Jan; 375(1-2):119-23. PubMed ID: 16889762 [TBL] [Abstract][Full Text] [Related]
28. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B. Demirdag K; Yilmaz S; Ozdarendeli A; Ozden M; Kalkan A; Kilic SS Hepatogastroenterology; 2003; 50(51):766-70. PubMed ID: 12828081 [TBL] [Abstract][Full Text] [Related]
29. Oxidative stress status in patients with acute urticaria. Kalkan G; Seçkin HY; Duygu F; Akbaş A; Ozyurt H; Sahin M Cutan Ocul Toxicol; 2014 Jun; 33(2):109-14. PubMed ID: 23841807 [TBL] [Abstract][Full Text] [Related]
30. Oxidative stress status and plasma trace elements in patients with asthma or allergic rhinitis. Sagdic A; Sener O; Bulucu F; Karadurmus N; Özel HE; Yamanel L; Tasci C; Naharci I; Ocal R; Aydin A Allergol Immunopathol (Madr); 2011; 39(4):200-5. PubMed ID: 21550164 [TBL] [Abstract][Full Text] [Related]
31. Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU). Burton BK; Bausell H; Katz R; Laduca H; Sullivan C Mol Genet Metab; 2010; 101(2-3):110-4. PubMed ID: 20638313 [TBL] [Abstract][Full Text] [Related]
32. Depression, anxiety, and stress in young adults with phenylketonuria: associations with biochemistry. Clacy A; Sharman R; McGill J J Dev Behav Pediatr; 2014; 35(6):388-91. PubMed ID: 25007061 [TBL] [Abstract][Full Text] [Related]
33. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients. Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms regulating superoxide generation in experimental models of phenylketonuria: an essential role of NADPH oxidase. Lu L; Gu X; Li D; Liang L; Zhao Z; Gao J Mol Genet Metab; 2011 Nov; 104(3):241-8. PubMed ID: 21640623 [TBL] [Abstract][Full Text] [Related]
35. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373 [TBL] [Abstract][Full Text] [Related]
36. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). Madan K; Bhardwaj P; Thareja S; Gupta SD; Saraya A J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114 [TBL] [Abstract][Full Text] [Related]
37. Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Ozgocmen S; Kaya H; Fadillioglu E; Yilmaz Z Arch Med Res; 2007 Feb; 38(2):196-205. PubMed ID: 17227729 [TBL] [Abstract][Full Text] [Related]
38. Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome. Baskol G; Aygen E; Erdem F; Caniklioğlu A; Narin F; Sahin Y; Kaya T Acta Obstet Gynecol Scand; 2012 Mar; 91(3):326-30. PubMed ID: 22168506 [TBL] [Abstract][Full Text] [Related]
39. Oxidant stress and B vitamins status in patients with non-small cell lung cancer. Tsao SM; Yin MC; Liu WH Nutr Cancer; 2007; 59(1):8-13. PubMed ID: 17927496 [TBL] [Abstract][Full Text] [Related]
40. NOX, the main regulator in oxidative stress in experimental models of phenylketonuria? He Y; Gu X; Lu L; Liang L; Gao J; Zhang X J Pediatr Endocrinol Metab; 2013; 26(7-8):675-82. PubMed ID: 23612646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]